Journal List > Tuberc Respir Dis > v.62(6) > 1001102

Lee, Cho, Kim, Park, Kim, Lee, Kim, Jeon, Park, Lee, and Park: Relations between Polymorphism of NRAMP1 Gene and Susceptibility to Pulmonary Tuberculosis

Abstract

Background

Several lines of evidence suggest that a host's genetic factors influence the outcome of exposure to Mycobacterium tuberculosis. The aim of this study was to determine whether polymorphism in NRAMP1 (natural resistance associated macrophage protein 1) gene is associated with the susceptibility or resistance to tuberculosis infection for patients with drug-sensitive pulmonary tuberculosis (DS-TB) and multi-drug resistant pulmonary tuberculosis (MDR-TB).

Methods

Eight genetic polymorphisms of the NRAMP1 gene were investigated in patients suffering with DS-TB (n=100) or MDR-TB (n=102), and in healthy normal controls (NC, n=96). The genetic polymorphisms of NRAMP1 were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

Results

The frequency of D543N A/G heterogygotes was significantly higher in the DS-TB subjects than the NCs (OR=2.10, 95% CI: 1.00 to 4.41, p=0.049). The frequency of 823C/T T/C heterozygotes was significantly higher in the DS-TB subjects (OR=2.79, 95% CI: 1.11 to 7.04, p=0.029) and the MDR-TB subject (OR=3.30, 95% CI 1.33 to 8.18, p=0.010) than in the NCs. However, the frequency of these genotypes was not different between the DS-TB and MDR-TB subjects.

Conclusion

A significant association was found between NRAMP1 823 C/T polymorphism and pulmonary tuberculosis. This result suggests that NRAMP1 polymorphism may be involved in the development of pulmonary tuberculosis in Koreans.

Figures and Tables

Table 1
Identification of NRAMP1 polymorphisms
trd-62-492-i001
Table 2
Demographic characteristics of subjects
trd-62-492-i002

DS-TBL: Drug sensitive tuberculosis; MDR-TB: Multi-drug resistant tuberculosis.

*Data are Mean ± standard deviation.

Table 3
Genotype frequencies of NRAMP1
trd-62-492-i003

NC: Normal control; DS-Tb: Dug sensitive tuberculosis; MDR-Tb: Multi drug resistance tuberculosis; OR: Odds ratio; CI: Confidence interval. NS: Not significant p>0.05.

References

1. Murray JF. A century of tuberculosis. Am J Respir Crit Care Med. 2004. 169:1181–1186.
2. Murray CJ, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis. 1990. 65:6–24.
3. Bellamy R. Genetic susceptibility to tuberculosis in human populations. Thorax. 1998. 53:588–593.
4. Marquet S, Schurr E. Genetics of susceptibility to infectious diseases: tuberculosis and leprosy as examples. Drug Metab Dispos. 2001. 29:479–483.
5. Schurr E, Buschman E, Malo D, Gros P, Skamene E. Immunogenetics of mycobacterial infections: mouse-human homologies. J Infect Dis. 1990. 161:634–639.
6. Plant J, Glynn AA. Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis. 1976. 133:72–78.
7. Blackwell JM, Roach TI, Atkinson SE, Ajioka JW, Barton CH, Shaw MA. Genetic regulation of macrophage priming/activation: the Lsh gene story. Immumol Lett. 1991. 30:241–248.
8. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 1993. 73:469–485.
9. Cellier M, Govoni G, Vidal S, Kwan T, Groulx N, Liu J, et al. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J Exp Med. 1994. 180:1741–1752.
10. Liu J, Fujiwara TM, Buu NT, Sanchez FO, Cellier M, Paradis AJ, et al. Identification of polymorphism and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet. 1995. 56:845–853.
11. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in west africans. N Engl J Med. 1998. 338:640–644.
12. Kim HS, Park MH, Song EY, Park H, Kwon SY, Han SK, et al. Association of HLA-DR and HLA-DQ genes with susceptibility to pulmonary tuberculosis in Koreans: preliminary evidence of associations with drug resistance, disease severity, and disease recurrence. Hum Immunol. 2005. 66:1074–1081.
13. Rajalingam R, Mehra NK, Jain RC, Myneedu VP, Pande JN. Polymerase chain reaction-based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. J Infect Dis. 1996. 173:669–676.
14. Dubaniewicz A, Lewko B, Moszkowska G, Zamorska B, Stepinski J. Molecular subtypes of the HLA-DR antigens in pulmonary tuberculosis. Int J Infect Dis. 2000. 4:129–133.
15. Sharma SK, Turaga KK, Balamurugan A, Saha PK, Pandey RM, Jain NK, et al. Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study. Infect Genet Evol. 2003. 3:183–188.
16. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis. 1978. 117:621–624.
17. Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc. 1942. 47:549–574.
18. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med. 1990. 322:422–427.
19. Rojas M, Barrera F, Puzo G, Garcia LF. Differential induction of apoptosis by virulent Mycobacterium Tuberculosis in resistant and susceptible murine macrophage. J Immunol. 1997. 159:1352–1361.
20. Xu DL, Goto Y, Endo F, Amoako KK, Shinjo T. The effect of Bcg gene on antigen presentation of spleen adherent cells and peritoneal macrophages from Mycobacterium bovis BCG-infected Bcgs and Bcgr mice. Vet Mocrobiol. 1997. 59:67–78.
21. Gruenheid S, Pinner E, Desjardins M, Gros P. Natural resistance to infection with intracellular parasites: The Nramp1 protein is recruited to the membrane of the phagosome. J Exp Med. 1997. 185:717–730.
22. Blackwell JM, Searle S. Genetic regulation of macrophage activation: understanding the function of NRAMP1(=Ity/Lsh/Bcg). Immun Letter. 1999. 65:73–80.
23. Govoni G, Gros P. Macrophage NRAMP1 and its role in resistance to microbial infections. Inflamm Res. 1998. 47:277–284.
24. Deretic V, Fratti RA. Mycobacterium tuberculosis phagosome. Mol Microbiol. 1999. 31:1603–1609.
25. Shaw MA, Collins A, Peacock CS, Miller EN, Black GF, Sibthorpe D, et al. Evidence that genetic susceptibility to Mycobacterium tuberculosis in an Brazilian population is under oligogenic control: linkage study of the candidate gene NRAMP1 and TNFA. Tuber Lung Dis. 1997. 78:35–45.
26. Blackwell JM. Genetics of host resistance and susceptibility to intramacrophage pathogens: a study of multicase families of tuberculosis, leprosy and leishmaniasis in north-eastern Brazil. Int J Parasitol. 1998. 28:21–28.
27. Huang JH, Oefner PJ, Adi V, Ratnam K, Ruoss SJ, Trako E, et al. Analyses of the NRAMP1 and IFN-γ R1 genes in women with Mycobacterium avium-intracellulare pulmonary disease. Am J Respir Crit Care Med. 1998. 157:377–381.
TOOLS
Similar articles